Medical software, SaMD, IVD & E-Health Registration Regulatory Requirements Reduction In Israel

Regulatory Reform for Medical Software SaMD and IVD Registration in Israel

The Bottom Line for Digital Health Innovators and Importers:
The Israeli Ministry of Health (IMOH) has launched a pioneering reform within the AMAR division that fundamentally changes how Medical Software, SaMD, and IVD devices enter the market. By transitioning toward a streamlined, risk-based classification system, the IMOH is removing traditional bureaucratic obstacles to foster a more competitive healthcare ecosystem. For international developers this means significantly reduced timelines and accelerated market access provided you have the right local regulatory partner to manage the new self-declaration and accelerated tracks.

In a groundbreaking development Israel Ministry of Health (IMOH) has initiated a significant shift in its AMAR division. This transition moves from traditional medical device registration to encompass the realm of medical software, SaMD (Software as a Medical Device), and IVD (In Vitro Diagnostic) devices with a strong focus on registration and marketing procedures in Israel. This pioneering reform marks a decisive departure from conventional bureaucratic complexities and paves the way for a more streamlined regulatory environment tailored to foster growth and innovation.

The AMAR Division in the Israeli MOH

In the domain of medical software, SaMD, IVD, and other digital health and E-Health services Israel central regulatory authority is the Medical Device Division within the Ministry of Health often referred to as AMAR. AMAR plays a pivotal role in overseeing various facets of registration, submissions, and meticulous control across development, integrity, reliability, accuracy, clinical evaluation, quality, information security, marketing, and post-marketing surveillance activities within Israel.

At its core AMAR orchestrates the issuance of diverse permits for importing medical software, SaMD, and IVD devices while rigorously overseeing every step of the marketing journey. It is equally renowned for disseminating essential documents, guidelines, and procedures serving as invaluable resources guiding the import process for such products developed abroad and intended for the Israeli market.

New Regulations for Medical Software SaMD and IVD Registration and Import

This transformative reform introduces a remarkable reduction in registration timelines for medical software, SaMD, and IVD devices. The new framework promises to revolutionize the landscape of import and marketing activities. Built upon a risk-based classification system the IMOH reform introduces an innovative pathway for expedited approvals.

Key Changes Based on Risk Classification in Israel

Just like medical device classification in the FDA and the CE medical software, SaMD, and IVD are classified based on risks to determine the regulatory pathway.

Classification	Regulatory Pathway	Approval Timeline
Class I	Low-risk Medical Software and IVD.	Immediate approval through a self-declaration process.
Class II	Moderate-risk Medical Software and SaMD.	Accelerated 60-day track contingent upon recognition by reputable nations like the USA and Europe.
Class III	High-risk Medical Software and IVD.	Registration procedures remain unchanged and require full AMAR review.

Software SaMD and IVD Registration Renewals in Israel

All types of Medical Software, SaMD, and IVD will have the option to renew notifications based on European and USA regulations. Additionally there will be a distinction between non-essential and essential changes following the adoption of European Union directives (MDR). For substantial changes a Service Level Agreement (SLA) is established to ensure predictable regulatory timelines.

The Future of Medical Software SaMD and IVD Registration in Israel

This transformative reform in the Israeli Ministry of Health shifts the responsibility for compliance to developers and importers while offering streamlined processes. The IMOH reform clears bureaucratic obstacles and creates a direct pathway to market entry marked by efficiency and timely access to cutting-edge solutions. This reform aligns seamlessly with Israel’s commitment to nurturing a competitive market ecosystem.

With the annual medical device and SaMD market nearing 10 billion NIS per year the anticipated annual savings of over 100 million NIS signal an era of affordability and innovation. This ensures a diverse range of innovative devices for Israeli consumers, hospitals, and clinics. Amidst this transformative period Eran Yona emerges as a steadfast partner focused on registration and facilitating importing and exporting endeavors including a local Registration Holder service.

Frequently Asked Questions

What does the 60 day accelerated track for Class II SaMD require?
To qualify for the 60-day track the software must already be registered and recognized by reputable regulatory bodies in countries like the USA or within the European Union.

How does the self-declaration process work for Class I devices?
For low-risk Class I Medical Software and IVD the importer can submit a self-declaration of compliance to AMAR which allows for immediate approval and market entry without the traditional lengthy review.

Who is responsible for compliance under the new IMOH reform?
The reform shifts significant responsibility to the SaMD developers and importers. This makes having a professional Israeli Registration Holder even more critical to ensure all self-declarations and renewals are legally sound.